← Back to Clinical Trials
Recruiting NCT07072143
An International Study on Pediatric Patients With Rare Tumors.
Trial Parameters
Condition Paraganglioma/ Phaeochromocytoma
Sponsor Azienda Ospedaliera di Padova
Study Type OBSERVATIONAL
Phase N/A
Enrollment 6,250
Sex ALL
Min Age 0 Years
Max Age 18 Years
Start Date 2025-01-25
Completion 2049-01-06
All Conditions
Paraganglioma/ Phaeochromocytoma Melanoma and Other Malignant Neoplasms of Skin Gastrointestinal Stromal Tumor (GIST) Adrenocortical Tumor Pancreatic Tumors Esthesioneuroblastoma, Olfactory Mesothelioma Nasopharyngeal Carcinoma (NPC) NUT Carcinoma Pleuropulmonary Blastoma Salivary Gland Tumors Thymic Tumors Thyroid Carcinoma Appendiceal Cancers
Brief Summary
The PARTNER study is an international, prospective, observational study of paediatric patients with very rare tumours.
Eligibility Criteria
Inclusion Criteria: * Children and adolescents (age 0-18 years) with a primary or relapsed Very Rare Tumor diagnosed and/or treated in a participating country/center. * Written informed consent from the patient and/or the parent/legal guardian Exclusion Criteria: * Absence of Written informed consent from the patient and/or the parent/legal guardian